Research agenda for medical cannabis in palliative care.

Gurgenci, T; Hardy, J; Good, P

Research agenda for medical cannabis in palliative care.

Gurgenci, T Hardy, J Good, P

Permalink

Publisher:: BMJ Publishing Group
Publication Type:: Journal Article
Citation:: BMJ Supportive and Palliative Care, 2022, 12, (3), pp. 299-301
Issue Date:: 2022-06-14

Closed Access

	Filename	Description	Size
	State.pdf		201.85 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Gurgenci, T
dc.contributor.author	Hardy, J
dc.contributor.author	Good, P https://orcid.org/0000-0002-8198-0375
dc.date.accessioned	2022-11-24T05:32:56Z
dc.date.available	2022-05-24
dc.date.available	2022-11-24T05:32:56Z
dc.date.issued	2022-06-14
dc.identifier.citation	BMJ Supportive and Palliative Care, 2022, 12, (3), pp. 299-301
dc.identifier.issn	2045-435X
dc.identifier.issn	2045-4368
dc.identifier.uri	http://hdl.handle.net/10453/163729
dc.description.abstract	The clinician-patient divide may in part be explained by the disruptive journey MC has taken into the clinical armamentarium. Most medications are conceived in the laboratory or discovered in nature without any strong prior expectations. As such, they are unencumbered by emotional baggage. In contrast, cannabis has been consumed for thousands of years across many cultures. Like any enduring cross-cultural phenomenon, individuals within the culture will have been exposed to it and have formed an opinion of it. Strong prior expectations of clinical utility - positive or negative - inevitably produce some degree of cognitive dissonance when these expectations are juxtaposed with the ambiguous literature.
dc.format	Print-Electronic
dc.language	eng
dc.publisher	BMJ Publishing Group
dc.relation.ispartof	BMJ Supportive and Palliative Care
dc.relation.isbasedon	10.1136/bmjspcare-2022-003747
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject	1110 Nursing, 1117 Public Health and Health Services
dc.title	Research agenda for medical cannabis in palliative care.
dc.type	Journal Article
utslib.citation.volume	12
utslib.location.activity	England
utslib.for	1110 Nursing
utslib.for	1117 Public Health and Health Services
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney/Faculty of Health/IMPACCT
utslib.copyright.status	closed_access	*
pubs.consider-herdc	false
dc.date.updated	2022-11-24T05:32:54Z
pubs.issue	3
pubs.publication-status	Published
pubs.volume	12
utslib.citation.issue	3

Abstract:

The clinician-patient divide may in part be explained by the disruptive journey MC has taken into the clinical armamentarium. Most medications are conceived in the laboratory or discovered in nature without any strong prior expectations. As such, they are unencumbered by emotional baggage. In contrast, cannabis has been consumed for thousands of years across many cultures. Like any enduring cross-cultural phenomenon, individuals within the culture will have been exposed to it and have formed an opinion of it. Strong prior expectations of clinical utility - positive or negative - inevitably produce some degree of cognitive dissonance when these expectations are juxtaposed with the ambiguous literature.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/163729